Boai NKY Valuation
| 300109 Stock | 14.79 0.19 1.27% |
At this time, the firm appears to be overvalued. Boai NKY Pharmaceuticals shows a prevailing Real Value of USD11.59 per share. The current price of the firm is USD14.79. Our model approximates the value of Boai NKY Pharmaceuticals from analyzing the firm fundamentals such as profit margin of 0.27 %, and Return On Equity of 0.11 as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.0708 | Enterprise Value 7.3 B | Enterprise Value Ebitda 17.0655 | Price Sales 4.8897 | Trailing PE 18.962 |
Overvalued
Today
Please note that Boai NKY's price fluctuation is somewhat reliable at this time. Calculation of the real value of Boai NKY Pharmaceuticals is based on 3 months time horizon. Increasing Boai NKY's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Boai NKY is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Boai Stock. However, Boai NKY's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.79 | Real 11.59 | Hype 14.85 | Naive 14.57 |
The real value of Boai Stock, also known as its intrinsic value, is the underlying worth of Boai NKY Pharmaceuticals Company, which is reflected in its stock price. It is based on Boai NKY's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Boai NKY's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Boai NKY Pharmaceuticals helps investors to forecast how Boai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Boai NKY more accurately as focusing exclusively on Boai NKY's fundamentals will not take into account other important factors: Boai NKY Cash |
|
Boai NKY Total Value Analysis
Boai NKY Pharmaceuticals is presently estimated to have takeover price of 7.34 B with market capitalization of 7.26 B, debt of 60.41 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Boai NKY fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.34 B | 7.26 B | 60.41 M |
Boai NKY Investor Information
About 25.0% of the company shares are owned by insiders or employees . The book value of Boai NKY was presently reported as 7.23. The company last dividend was issued on the 7th of June 2024. Boai NKY Pharmaceuticals had 1.56:1 split on the 7th of June 2024. Based on the key measurements obtained from Boai NKY's financial statements, Boai NKY Pharmaceuticals is performing exceptionally good at this time. It has a great probability to report excellent financial results in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 512.7 M | 488.3 M |
|
| |||||
| Operating Income | 643.6 M | 613 M |
|
|
Boai NKY Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Boai NKY has an asset utilization ratio of 39.56 percent. This suggests that the Company is making USD0.4 for each dollar of assets. An increasing asset utilization means that Boai NKY Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Boai NKY Ownership Allocation
Boai NKY holds a total of 484.7 Million outstanding shares. Boai NKY Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Boai NKY Profitability Analysis
The company reported the revenue of 1.59 B. Net Income was 485.79 M with profit before overhead, payroll, taxes, and interest of 690.63 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Boai NKY's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Boai NKY and how it compares across the competition.
About Boai NKY Valuation
The stock valuation mechanism determines Boai NKY's current worth on a weekly basis. Our valuation model uses a comparative analysis of Boai NKY. We calculate exposure to Boai NKY's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Boai NKY's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 901.1 M | 946.2 M |
Boai NKY Quarterly Retained Earnings |
|
Complementary Tools for Boai Stock analysis
When running Boai NKY's price analysis, check to measure Boai NKY's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boai NKY is operating at the current time. Most of Boai NKY's value examination focuses on studying past and present price action to predict the probability of Boai NKY's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boai NKY's price. Additionally, you may evaluate how the addition of Boai NKY to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |